Status: Recruiting
A Study of IBI362 in Chinese Adolescents With Obesity or Overweight
The study is designed to assess the efficacy and safety of multiple doses of IBI362 in Chinese adolescent subjects with obesity or overweight. It plans to enroll 180 adolescents (aged ≥12 and \<18 years) who have failed to achieve a 5 kg weight reduction after at least 12 weeks of dietary and exercise intervention.
Participants needed: 180
Trial details
Phase: Phase 3Age: 12-18Biological sex: AllType: InterventionalSponsor: Innovent Biologics (Suzhou) Co. Ltd.Updated: Jan 8, 2026Locations: 1
Eligibility criteria
Male or female participants aged ≥12 years and <18 years at the time of signing... [+2]
Prior diagnosis of type 1 diabetes. [+2]